Cognition and Imaging With Tigertriever
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Rapid Medical
- Study ID
- NCT05531461
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Study Details
The objective of the COGNITIVE Study is to evaluate whether successful reperfusion with Tigertriever is associated with cognitive benefit.
Key Dates
- Start date
- Oct 28, 2024
- Status verified
- Mar 2025
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2026
Study Design
- Enrollment
- 424 participants (estimated)
Primary Outcome Measure
Association between successful reperfusion* and cognitive benefit** [ Time Frame: 180 days post treatment ]
Central Contacts
- Walid Haddad, Dr.+972 72 2503331
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California | Los Angeles | California | 90095 | Tateshima Satoshi, MD (PRINCIPAL_INVESTIGATOR) |
| Corewell Health Research Institute | Grand Rapids | Michigan | 49503 | Paul Mazaris, MD (PRINCIPAL_INVESTIGATOR) |
| Westchester Medical Center | New York | New York | 10595 | Chirag Gandhi (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Los Angeles, CA
By condition
By specialty
Related Studies
- Genetic and Environmental Risk Factors for Hemorrhagic StrokeRecruiting · State University of New York at Buffalo · Chicago, Illinois
- Infliximab Therapy for Dolichoectactic Vertebrobasilar AneurysmsPHASE1/PHASE2 · Recruiting · University of California, San Francisco · San Francisco, California
- Stroke Recovery Initiative - Registry for Stroke Research StudiesRecruiting · University of California, San Francisco · San Francisco, California
- Traumatic Brain Injury and Stroke Long Term OutcomeRecruiting · Centre for Neuro Skills · Encino, California